BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25943864)

  • 21. Adenocarcinoma In Situ of the Uterine Cervix (AIS) Treated by Loop Electrosurgical Excision Procedure Strategy: An Observational Study.
    Soegaard-Andersen E; Frandsen AP; Sandahl P
    J Low Genit Tract Dis; 2024 Apr; 28(2):149-152. PubMed ID: 38251975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized prospective study comparing three techniques of conization: cold knife, laser, and LEEP.
    Mathevet P; Dargent D; Roy M; Beau G
    Gynecol Oncol; 1994 Aug; 54(2):175-9. PubMed ID: 8063242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is laser conization adequate for therapeutic excision of adenocarcinoma in situ of the uterine cervix?
    Akiba Y; Kubushiro K; Fukuchi T; Fujii T; Tsukazaki K; Mukai M; Nozawa S
    J Obstet Gynaecol Res; 2005 Jun; 31(3):252-6. PubMed ID: 15916663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors influencing decisions about surgical treatment of villoglandular adenocarcinoma of the uterine cervix.
    Kim HJ; Sung JH; Lee E; Ahn S; Song SY; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Int J Gynecol Cancer; 2014 Sep; 24(7):1299-305. PubMed ID: 24987921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on the clinicopathologic features of 88 cases with mucinous cervical adenocarcinoma].
    Zeng SY; Zhong ML; Liang MR; Li L; Jiang W; Yu XH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):602-6. PubMed ID: 24199926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma in situ.
    Munro A; Codde J; Spilsbury K; Steel N; Stewart CJ; Salfinger SG; Tan J; Mohan GR; Leung Y; Semmens JB; O'Leary P; Williams V; Cohen PA
    Am J Obstet Gynecol; 2017 Mar; 216(3):272.e1-272.e7. PubMed ID: 27908632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of HPV testing in the follow-up of women treated for cervical dysplasia.
    Ribaldone R; Boldorini R; Capuano A; Arrigoni S; Di Oto A; Surico N
    Arch Gynecol Obstet; 2010 Aug; 282(2):193-7. PubMed ID: 20012636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient loop electrosurgical excision procedure for cervical intraepithelial neoplasia. Can it replace cold knife conization?
    Eduardo AM; Dinh TV; Hannigan EV; Yandell RB; Schnadig VJ
    J Reprod Med; 1996 Oct; 41(10):729-32. PubMed ID: 8913973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical adenocarcinoma in situ: the predictive value of conization margin status.
    Young JL; Jazaeri AA; Lachance JA; Stoler MH; Irvin WP; Rice LW; Andersen WA; Modesitt SC
    Am J Obstet Gynecol; 2007 Aug; 197(2):195.e1-7; discussion 195.e7-8. PubMed ID: 17689647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conservative Treatment for Cervical Adenocarcinoma In Situ: Long-Term Results.
    Monti E; Somigliana E; Alberico D; Boero V; Iorio M; Di Loreto E; Dell'acqua A; Liverani CA
    J Low Genit Tract Dis; 2022 Oct; 26(4):293-297. PubMed ID: 35917498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fertility and Pregnancy Outcomes After Conservative Management of Adenocarcinoma In Situ of the Cervix.
    Bell SG; Peng K; Kobernik EK; Miller ME; Lieberman R; Saunders NA; Welch KC; Campbell EJ
    J Low Genit Tract Dis; 2021 Oct; 25(4):270-275. PubMed ID: 34369435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How I do… a cylindrical excision for in situ adenocarcinoma of the cervix].
    Azaïs H; Canlorbe G; Belghiti J; Nikpayam M; Mergui JL; Uzan C
    Gynecol Obstet Fertil Senol; 2017; 45(7-8):439-440. PubMed ID: 28711365
    [No Abstract]   [Full Text] [Related]  

  • 40. PTEN Loss and ARID1A Mutation in an HPV-positive Metastatic Adenocarcinoma Diagnosed Almost 18 yr After an Intact Cone Excision for Endocervical Adenocarcinoma In Situ.
    Aisagbonhi O; Zare SY; Hasteh F; Binder P; Roma AA; Fadare O
    Int J Gynecol Pathol; 2022 May; 41(3):307-312. PubMed ID: 34282106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.